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1. Introduction
Noncoding RNAs (ncRNAs) are an attractive research field to prompt extensive 
genome-wide transcriptional efforts by different international initiatives such as the 
Encyclopedia of DNA Elements (ENCODEs) [1] and the Functional Annotation of 
the Mammalian Genome (FANTOM) [2]. Existence of ncRNAs is ubiquitous to all 
three domains of life, but they play different roles according to type of its RNA  family 
[3, 4]. Dysfunction of ncRNAs may lead to various human diseases from tumorigen-
esis to neurological, cardiovascular, and developmental disorders [5]. Hence, ncRNAs 
have become a hot topic in molecular genetic and epigenetic research.
Findings of Human Genome Project have disclosed that approximately 1.5% 
of human genome is comprised of protein encoding genes. On the other hand, 
the majority of the human genome is transcribed and yields ncRNAs. Noncoding 
RNAs, which are not translated as peptides or proteins, may be categorized as 
housekeeping noncoding RNAs and regulatory noncoding RNAs. Noncoding RNAs 
may be grouped into two major classes based on their size: small noncoding RNAs 
(sncRNAs) are shorter than 200 nucleotides (nts) in length and long noncoding 
RNAs (lncRNAs) are longer than 200 nts. Albeit these RNAs are named as noncod-
ing, some lncRNAs code for small bioactive peptides [6, 7].
SncRNAs accorporate functional RNAs including r-RNAs, snRNAs, and 
t-RNAs, which play important roles in transcriptional and translational regula-
tions. Furthermore, sncRNAs also contain regulatory RNAs, which play roles in 
gene expression such as P-element-induced wimpy testis (PIWI) interacting RNAs 
(piRNAs), small interfering RNAs (siRNAs), and microRNAs (miRNAs). Per con-
tra, lncRNAs represent a large group of noncoding regulatory RNAs. The lncRNAs 
are divided according to their mode of action, such as natural antisense transcripts 
(NATs), intergenic (lincRNAs), intronic lncRNAs, circular RNAs (circRNAs), 
promoter-associated long RNAs (pRNAs), and enhancer RNAs (eRNAs).
2. miRNAs and siRNAs
siRNAs and miRNAs are 19–24 nts in size and silent transcription of genes via 
inducing mRNA degradation or translational repression. Generally, protein-coding 
genes are negatively regulated by a single miRNA or multiple miRNAs [8]. While 
miRNAs originated from pri-miRNAs, source of siRNAs is double-stranded RNAs. 
Moreover, miRNAs potentially play important roles in biological processes in a 
cell such as cell differentiation, cell proliferation, cell death, and development by 
 inducing mRNA degradation or translational repression. Dysregulation of miRNAs 
leads to several human diseases including cancer, cardiovascular, and neurodegen-
erative diseases [9].
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3. piRNAs
piRNAs are 21–35 nts long and originated from long single-chain precursor 
transcripts. Their main functions are transposon repression, DNA methylation, 
silencing transposable elements, regulating gene expression, and fighting with 
viral infections. PIWI proteins are guided by piRNAs to cleave target RNA, promote 
heterochromatin assembly, and methylate DNA [10]. Up- and downregulated 
expressions of piRNAs in several cancer types and Alzheimer’s disease suggest that 
piRNAs take part in several human diseases [11].
4. lncRNAs
lncRNAs are more than 200 nts long and originated in multiple ways and may be 
transcribed from both noncoding DNA by RNA polymerase II and protein coding 
(e.g., H19 and TUG1). LncRNA genes are more abundant than short ncRNAs and 
outnumber protein-coding genes. They mainly function in genomic imprinting 
and X-chromosome inactivation. Furthermore, they take roles in gene regulation, 
chromatin remodeling, cancer cell invasion, and metastasis and cell differentiation 
by acting as cis- or trans-regulators in biological processes [12]. Moreover, function 
of lncRNAs linked to some human diseases including hepatocellular carcinoma, 
Alzheimer’s disease, and diabetes [13].
5. Future perspectives
Mounting evidence and recent discoveries of novel short and long regulatory 
noncoding RNA classes revealed remarkable complexity of RNA-guided regula-
tion on biological processes in a cell. There is a complex problem between RNA 
regulatory network and protein-based regulatory mechanisms. Noncoding RNA 
regulatory network is a challenging process to analyze and untwist. For example, 
notwithstanding their size, both lncRNAs and miRNAs play regulatory roles on 
protein-coding genes at post-transcriptional repression, but also lncRNAs may act 
as miRNA sponges and may degrade regulatory effect on mRNA [14]. It is known 
that dysregulation of ncRNAs may stir up several diseases including cancer and 
neurodegenerative diseases. Hence, further development of bioinformatics, genome 
scanning, and biochemical techniques is required to illuminate detailed functions 
and interactions of ncRNAs. It is clear that further research on ncRNAs will change 
our understanding about the nature of genome composition by rummaging previ-
ous dogmas.
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